Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability

International Journal of Pharmaceutics

Volumn 396, Issue 1-2, 2010, Pages 210-218

  Cerdeira, Ana M ^a   Mazzotti, Marco ^b   Gander, Bruno ^b  

^a Cilag AG   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Drug solubility; Miconazole; Nanogrinding; Nanonization; Nanosuspension; Suspension stability

Indexed keywords

DODECYL SULFATE SODIUM; HYDROXYPROPYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MICONAZOLE; NANOPARTICLE; NANOSUSPENSION; POLOXAMER; POVIDONE; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; CELLULOSE; EXCIPIENT; NANOMATERIAL;

ARTICLE; CONTACT ANGLE; DRUG DESIGN; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; GRINDING; PARTICLE SIZE; PREFORMULATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SCREENING; STEREOSPECIFICITY; STORAGE TEMPERATURE; STORAGE TIME; THERMOSTABILITY; TIME; ANALOGS AND DERIVATIVES; CHEMICAL MODEL; CHEMISTRY; MEDICINAL CHEMISTRY; NANOTECHNOLOGY; PHARMACEUTICS; PROCEDURES; SOLUBILITY; TEMPERATURE; VISCOSITY;

ANTIFUNGAL AGENTS; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG STABILITY; DRUG STORAGE; EXCIPIENTS; MICONAZOLE; MODELS, CHEMICAL; NANOSTRUCTURES; NANOTECHNOLOGY; PARTICLE SIZE; SODIUM DODECYL SULFATE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TIME FACTORS; VISCOSITY;

EID: 77955052417     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.06.020     Document Type: Article

References (24)

1. Ain-Ai A., Gupta P.K. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. Int. J. Pharm. 2008, 351:282-288.
2. Augustijns P., Van den Mooter G., Van Eerdenbrugh B. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int. J. Pharm. 2008, 364:64-75.
3. Aulton M.E. Aulton's Pharmaceutics. The Design and Manufacture of Medicines 2007, Churchill Livingstone, Edingburgh, pp. 65, 78. 3rd ed.
4. Berglund D.K., Przybycien T.M., Tilton R.D. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 1. Role of polymer hydrophobic modification. Langmuir 2003, 19:2705-2713.
5. Choi J.-Y., Yoo J.Y., Kwak H.-S., Nam B.U., Lee J. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr. Appl. Phys. 2005, 5:472-474.
6. Crison J.R. Biopharmaceutical aspects of water-insoluble drugs for oral drug delivery. Water Insoluble Drug Formulation 2000, 98-108. Interpharm/CRC, Boca Raton. L. Rong (Ed.).
7. Evertsson H., Nilsson S. Microviscosity in clusters of ethyl hydroxyethyl cellulose and sodium dodecyl sulfate formed in dilute aqueous solutions as determined with fluorescence probe techniques. Macromolecules 1997, 30:2377-2385.
8. Gardner C.R., Walsh C.T., Almarsson O. Drugs as materials: valuing physical form in drug discovery. Nat. Rev. Drug Discov. 2004, 3:926-934.
9. Kesisoglou F., Panmai S., Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 2007, 59:631-644.
10. Kipp J.E. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int. J. Pharm. 2004, 284:109-122.
11. Kobierski S., Ofori-Kwakye K., Müller R.H., Keck C.M. Resveratrol nanosuspensions for dermal application-production, characterization, and physical stability. Pharmazie 2009, 64:741-747.
12. Kwade A. Wet comminution in stirred media mills-research and its practical application. Powder Technol. 1999, 105:14-20.
13. Lee J. Drug nano and microparticles in solid dosage forms. J. Pharm. Sci. 2003, 92:2057-2068.
14. Lee J., Choi J.-Y., Park C.H. Characteristics of polymers enabling nano-comminution of water insoluble drugs. Int. J. Pharm. 2008, 355:328-336.
15. Liversidge, G.G., Cundy, K.C., Bishop, J., Czekai, D., 1992. Surface modified drug nanoparticles. US Patent 5,145,684.
16. Merisko-Liversidge E., Liversidge G.G., Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 2003, 18:113-120.
17. Muller R.H., Jacobs C., Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 2001, 47:3-19.
18. Ploehn H.J., Russel W.B. Interactions between colloidal particles and soluble polymers. Adv. Chem. Eng. 1990, 15:137-228.
19. Rabinow B.E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 2004, 3:785-796.
20. Riley S. Innovation in Drug Delivery. Business Insights 2006.
21. Stenger F., Mende S., Schwedes J., Peukert W. Nanomilling in stirred media mills. Chem. Eng. Sci. 2005, 60:4557-4565.
22. Sweetman S. Martindale. The Complete Drug Reference 2006, Pharmaceutical Press, London. 35th ed.
23. Van Eerdenbrugh B., Vermant J., Martens J.A., Froyen L., Van Humbeeck J.V., Augustijns P., Van den Mooter G. A screening study of surface stabilization during the production of drug nanocrystals. J. Pharm. Sci. 2009, 98:2091-2103.
24. Verma S., Gokhale R., Burgess J.D. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int. J. Pharm. 2009, 380:216-222.